Ebola superspreading The Lancet Infectious Diseases

Slides:

Advertisements

Similar presentations

The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)

Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Risk of outbreak of vector-borne diseases in the tsunami hit areas of southern India K Balaraman, Dr S Sabesan, P Jambulingam, K Gunasekaran, PS Boopathi.

Pathogenesis of urinary tract infections with normal female anatomy

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

ZIKA App – A great resource from the World Health Organization (WHO)

Volume 357, Issue 9257, Pages (March 2001)

Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:

Thank God for Richard Dawkins?

Brian J Coburn, David J Gerberry, Sally Blower

Chikungunya, the emerging migratory rheumatism

Author gender in The Lancet journals

Controlling Ebola: key role of Ebola treatment centres

The post-Ebola baby boom: time to strengthen health systems

Infections related to totally implantable venous-access ports

Zika virus: following the path of dengue and chikungunya?

John N Nkengasong, Philip Onyebujoh The Lancet

Underestimate of annual malaria imports to Canada – Author reply

Klebsiella pneumoniae liver abscesses

Ebola virus epidemic in war-torn eastern DR Congo

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study Matthew Waxman, MD,

Ebola control: effect of asymptomatic infection and acquired immunity

Lauren M Gardner, Nan Chen, Sahotra Sarkar

Ebola: fever definitions might delay detection in non-epidemic areas

Ebola: worldwide dissemination risk and response priorities

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Rising food insecurity in Europe

Constantly high incidence of scarlet fever in Germany

Clarification of INTERGROWTH-21st newborn birthweight standards

Breastfeeding in the 21st century

Brian J Coburn, Sally Blower The Lancet Infectious Diseases

Ebola: fever definitions might delay detection in non-epidemic areas

Until eradication, awareness

Disease and stigma The Lancet Volume 354, (December 1999)

Low risk of a sexually-transmitted Zika virus outbreak

HIV myths should not be resuscitated

Challenges to eliminate rabies virus infection in China by 2020

Modelling the effect of early detection of Ebola

Community-based care of Ebola virus disease in west Africa

The velocity of Ebola spread in parts of west Africa

Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP

Hepatitis A outbreaks The Lancet Infectious Diseases

Zika virus: following the path of dengue and chikungunya?

Confessions of a journal junkie

Infant-feeding patterns and HIV-1 transmission

Errata The Lancet Infectious Diseases

Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer

Telling it like it isn't: truth and lies in a post-9/11 world

Outbreak reporting a decade after ORION: where do we stand?

Availability of essential diagnostics in primary care in India

Thank God for Richard Dawkins?

Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis Joseph A Lewnard, BA, Martial L Ndeffo Mbah,

Low-technology approaches

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

Artefenomel: a promising new antimalarial drug

Procalcitonin as a diagnostic marker for sepsis

Steven A Narod The Lancet Volume 349, Issue 9068, (June 1997)

The 2009 influenza pandemic

Infections related to totally implantable venous-access ports

Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:

Dengue pre-vaccination screening and positive predictive values

A remarkable report card on progress in COPD

Ebola control: rapid diagnostic testing

Difficulties of surgery in the developing world: a personal view

A 12 year outbreak of scarlet fever in Singapore

Ebola control: effect of asymptomatic infection and acquired immunity

Volume 349, Issue 9062, Pages (May 1997)

Symptom-based stratification of autoimmune diseases

Sickle cell disease: a new era

Autism, maths, and sex: the special triangle

Presentation transcript:

Ebola superspreading The Lancet Infectious Diseases Christian L Althaus The Lancet Infectious Diseases Volume 15, Issue 5, Pages 507-508 (May 2015) DOI: 10.1016/S1473-3099(15)70135-0 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure Distribution of the number of secondary cases and outbreak trajectories for Ebola virus disease (A) The histogram represents the observed frequencies in the number of secondary cases as given by the transmission trees in Faye and colleagues' study.1 The line and dots correspond to the fitted negative binomial distribution. (B) Each line represents one of 200 stochastic realisations of epidemic trajectories. Dots show when the outbreak becomes extinct. A detailed analysis is reported in the appendix. EVD=Ebola virus disease. The Lancet Infectious Diseases 2015 15, 507-508DOI: (10.1016/S1473-3099(15)70135-0) Copyright © 2015 Elsevier Ltd Terms and Conditions